Author: Vitaliy Dadalyan

Shell Shares Fall to 25-Year Low After Reorganization Update

(Bloomberg) -- Royal Dutch Shell Plc dropped to the lowest in 25 years a day after announcing a companywide overhaul, demonstrating the scale of the challenge the biggest oil companies face convincing investors about their green ambitions.Along with its European peers, Shell is embarking on a transformation to become a cleaner, greener company with much fewer assets in oil by the middle of the century. While many investors have welcomed the new direction, others question a pivot into less-profitable renewablesShell’s B shares closed at 907.3 pence on Thursday, the lowest level since November 1995. It’s London-based competitor BP Plc also fell to a 25-year low for a second week running, closing at 218.2 pence.The Anglo-Dutch major announced Wednesday as many as 9,000 job losses by the end of 2022, which it predicts will result in cost savings of as much as $2.5 billion dollars. The redundancies are part of a wider...

Mesoblast Shares Halted: A Look At The Biopharma's Upcoming Catalysts

Trading in shares of Australian biopharma Mesoblast limited (NASDAQ: MESO) was halted on the Nasdaq exchange Wednesday pending the release of material news.The Mesoblast Trading Halt: Earlier, the Australian stock exchange made an announcement regarding the halt, stating that trading in Mesoblast stock was halted at the request of the company."Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Monday, 5 October 2020 or when the announcement is released to the market," the statement said. Mesoblast Has Long-Awaited Binary Event: Mesoblast is awaiting an FDA decision on its lead stem cell therapy candidate remestemcel-L -- trade name Rynocil -- for treating steroid-refractory acute graft versus host disease, or SR-aGVHD, in pediatric patients.The PDUFA date is set for Oct. 30; the trading halt is likely to be related to the pending decision.The disease is a complication arising from donor cells...

Boeing to move 787 production to South Carolina in 2021

Boeing Co said on Thursday it will move the rest of its 787 Dreamliner production to South Carolina in 2021, a cost-cutting strategy that raises questions over the future its giant Everett plant north of Seattle. Reuters first reported on Sept. 21 that Boeing was near a decision to move Dreamliner production to South Carolina as its strategy of supporting two plants has been severely tested by the coronavirus slump in international travel, on top of a cyclical downturn in demand for big jets. As recently as last year, Boeing was making record numbers of 787s at its Everett widebody hub north of Seattle and - since 2012 - a second plant in North Charleston, South Carolina....